Pre-eclampsia is associated with increased neurodevelopmental disorders in children with congenital heart disease

Camilla Omann1,2, Camilla Nyboe1,2, Rasmus Kristensen3

  • 1Department of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.

Insights

Exposure to pre-eclampsia significantly elevates the risk of neurodevelopmental disorders in children with congenital heart disease (CHD). These conditions may interact synergistically, increasing risk further.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Maternal-Fetal Medicine

Background:

  • Congenital heart disease (CHD) affects numerous children globally.
  • Neurodevelopmental disorders (NDDs) are a significant concern in children with CHD.
  • The impact of maternal pre-eclampsia on NDD risk in CHD offspring is not fully understood.

Purpose of the Study:

  • To investigate if maternal pre-eclampsia exposure increases NDD risk in children with CHD.
  • To determine if CHD and pre-eclampsia act synergistically to potentiate NDD risk.

Main Methods:

  • Population-based registry study of Danish children born with CHD (1994-2017).
  • Exclusion of non-singletons and children with syndromes.
  • Identification of NDDs using ICD-10 codes (DF80-DF98).
  • Cox proportional hazard regression and cumulative incidence analyses were employed.

Main Results:

  • Children with CHD exposed to pre-eclampsia showed an increased risk of NDDs (HR: 1.84, 95% CI: 1.39-2.42).
  • Pre-eclampsia exposure drastically increased the cumulative incidence of NDDs in children with CHD compared to those without CHD.

Conclusions:

  • Maternal pre-eclampsia is linked to a higher risk of NDDs in children with CHD.
  • A potential synergistic effect between CHD and pre-eclampsia amplifies NDD risk.
  • Clinicians should prioritize monitoring for neurodevelopmental issues in this high-risk group.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
46
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
33
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
71